Akebia Therapeutics Inc. buy BTIG Research
Start price
07.04.26
/
50%
€1.18
Target price
07.04.27
€3.47
Performance (%)
-37.53%
Price
08:17
?
Summary
This prediction is currently active. The BUY prediction by BTIG_Research for Akebia Therapeutics Inc. is performing very badly with a performance of -37.53%. This prediction currently runs until 07.04.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akebia Therapeutics Inc. | -32.313% | -32.313% |
| iShares Core DAX® | 0,44 % | 5,90 % |
| iShares Nasdaq 100 | 1,06 % | 0,92 % |
| iShares Nikkei 225® | 1,77 % | 1,23 % |
| iShares S&P 500 | 0,37 % | 1,92 % |
Comments by BTIG_Research for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics (AKBA) had its "buy" rating reaffirmed by BTIG Research. They now have a $4.00 price target on the stock.
Ratings data for AKBA provided by MarketBeat
Stopped prediction by BTIG_Research for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.08
25.02.26
25.02.26
€3.39
25.02.27
25.02.27
-29.67%
08:17
08:17
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.27
02.12.25
02.12.25
€4.31
02.12.26
02.12.26
-40.60%
08:17
08:17
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.93
29.10.25
29.10.25
€4.29
29.10.26
29.10.26
-60.75%
08:17
08:17
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.92
29.11.23
29.11.23
€3.64
29.11.24
29.11.24
122.78%
30.11.24
30.11.24